Riaan I-US Food and Drug Administration (FDA) igunyaze umthamo owodwa we-booster womuthi wokugomela i-Pfizer-BioNTech COVID-19 bivalent wezingane ezinezinyanga eziyisithupha kuya eminyakeni emine ubudala.
Okungenani izinyanga ezimbili ngaphambi kokuthola lesi sikhuthazi, izingane kumele ngabe seziqedile ukuqalwa kwemithamo emithathu uchungechunge lokugoma.
Izingane ezikulelo banga lobudala ezithole kuphela imithamo emibili yokuqala yomgomo we-Pfizer COVID-19 okwamanje azifaneleki ukuthola lesi sikhuthazo. I-FDA incoma ukuthi baqedele uchungechunge lwemithamo emithathu.
UKUNGALALI KUNGEHLISA AMA-ANTIBODIE OMGOMO, KUTHOLAKALA UCWANINGO OLUSHA
I-FDA ithe esimemezelweni sayo sokuthi Umgomo we-Pfizer-BioNTech COVID-19, i-Bivalent ihlanganisa ingxenye ye-mRNA enikeza impendulo “yokuvikela kabanzi” yokuzivikela ngokumelene ne-COVID-19, kanye nokuphikisana nezinhlobonhlobo ze-omicron BA.4 kanye ne-BA.5.
I-Food and Drug Administration (FDA) igunyaze umthamo owodwa we-booster womuthi wokugomela i-Pfizer-BioNTech COVID-19 wezingane ezinezinyanga eziyisithupha kuya eminyakeni emine ubudala ezike zaqeda uchungechunge lokugoma oluyisisekelo lwemithamo emithathu. (iStock)
“Ukugunyazwa kwanamuhla kunikeza abazali nabanakekeli bezingane izinyanga eziyisi-6 kuye kwemine ubudala abathole uchungechunge oluyisisekelo lwemithamo emithathu ngomuthi wokugomela i-Pfizer-BioNTech COVID-19 ithuba lokuvuselela ukuvikelwa kwezingane zabo ngokuthola umthamo okhuthazayo nge-Pfizer- I-BioNTech COVID-19 Vaccine, Bivalent, “kusho uPeter Marks, MD, PhD, umqondisi we-FDA’s Center for Biologics Evaluation and Research, esitatimendeni sabezindaba ememezela ukugunyazwa.
“Imininingwane etholakalayo njengamanje ikhombisa ukuthi ukugoma kusewukuzivikela okungcono kakhulu izifo ezinzima, ukulaliswa esibhedlela nokufa okubangelwa yi-COVID-19 kuwo wonke amaqembu eminyaka, ”engeza.
“Sikhuthaza bonke abantu abafanelekile ukuthi baqinisekise ukuthi imigomo yabo ihambisana ne-bivalent COVID-19,” esho.
Ngaphambi kokugunyaza i-booster, i-FDA yahlaziya idatha yokusabela kwamasosha omzimba ezinganeni ezingama-60 kuleli banga lobudala ezaziqede uchungechunge lwemithamo emithathu yokugoma ngaphezu komthamo okhuthazayo.
I-FDA iphinde yacaphuna ucwaningo lomtholampilo olwahlola izingane izinyanga eziyisithupha kuya eminyakeni eyi-11 eziphothule uchungechunge lwemithamo emithathu yokugoma kanye nethamo elikhuthazayo le-Pfizer-BioNTech. Umgomo we-covid-19Bivalent.
Izingane kufanele zibe seziqede uchungechunge lwazo lokugoma oluyisisekelo lwemithamo emithathu okungenani izinyanga ezimbili ngaphambi kokuthola isikhuthazi esisha. (iStock)
Umphumela ovame kakhulu phakathi kwezingane eziphakathi kwezinyanga eziyisithupha nezinyanga ezingu-23 wawukozela, ukucasuka, ubuhlungu nokuvuvukala, ububomvu bendawo yomjovo, ukuncipha kwesifiso sokudla, ukukhathala kanye nomkhuhlane, kuphawula i-FDA.
Ezinganeni eziphakathi kweminyaka emibili neminyaka emine ubudala, imiphumela engemihle evame kakhulu kwakuwukuhlanza, ikhanda elibuhlungu, ukukhathala, ubuhlungu bendawo yomjovo, isifo sohudo, ububomvu nokuvuvukala, ubuhlungu bamalunga nokugodola.
I-CDC Advisory GROUP ITHOLA UBUFAKAZI ABANGANENE BOKUNCOMA OKWENGEZIWE NGE-COVID-19 BOOSTER NGONYAKA
Kuleyo minyaka emihlanu kuya kweyi-11, imiphumela engemihle evame kakhulu kwakuwubuhlungu bemisipha, ubuhlungu bamalunga, ukukhathala, ikhanda elibuhlungu, imfiva, ukugodola, isifo sohudo, ukuhlanza, ubuhlungu bendawo yomjovo, ukuvuvukala nokubabomvu, nokuvuvukala kwama-lymph nodes.
Ngaphambi kokugunyaza i-booster entsha, i-FDA yahlaziya idatha yokusabela kwamasosha omzimba ezinganeni ezingama-60 kuleli banga lobudala ezaziqede uchungechunge lwemithamo emithathu yokugoma ngaphezu komthamo okhuthazayo. (REUTERS/Eric Gaillard)
I-FDA iphinde yacaphuna ezinye izifundo ezimbalwa ezisekela ukuphepha kwethamo le-booster elinconyiwe.
Lezi zifundo zihloliwe abantu abangaphezu kweminyaka engama-55 abathole i-booster, izingane ezinezinyanga eziyisithupha nangaphezulu ezithole uchungechunge lokugoma okuyinhloko, kanye nabantu abaneminyaka emihlanu nangaphezulu abathole ukugonywa kwe-booster ngomuthi wokugomela i-Pfizer-BioNTech COVID-19, owawugunyazwe ngaphambilini kodwa ongasekho.
“Ngenxa yokuthi umuthi wokugoma ugunyaziwe akusho ukuthi kufanele usetshenziswe ngokuzenzekelayo.”
UMarc Siegel, MD, uprofesa wezokwelapha kanye nomqondisi wezokwelapha weDokotela Radio at I-NYU Langone Medical Centerkanye nomnikeli wezokwelapha we-Fox News, uveze ukuthi ngenxa yokuthi umuthi wokugoma ugunyaziwe akusho ukuthi kufanele usetshenziswe ngokuzenzakalelayo.
“Lokho kufanele kube yingxoxo phakathi komzali nodokotela wezingane – kanye nengane,” etshela iFox News Digital nge-imeyili.
“Kufanele kusekelwe ezintweni ezifana nendlela ingane eyasabela ngayo ngaphambilini emgomeni.”
Ezinganeni eziphakathi kweminyaka emibili neminyaka emine ubudala, imiphumela engemihle evame kakhulu evela emgomeni ukuhlanza, ikhanda elibuhlungu, ukukhathala, ubuhlungu bendawo yomjovo, isifo sohudo, ububomvu nokuvuvukala, ubuhlungu bamalunga nokugodola. (iStock)
Wengeze ngokuthi ukusebenza kwemigomo kuyehla ngokuhamba kwesikhathi.
Amashidi amaqiniso anikezwe abamukeli bomuthi wokugoma, abanakekeli nabahlinzeki bezempilo axwayisa ngengozi ye-myocarditis ne-pericarditis, kuphawula i-FDA.
CHOFOZA LAPHA UKUZE Ubhalisele IPHEPHA LETHU LEZEMPILO
NgoFebhuwari, iCenters for Disease Control and Prevention (CDC) ibuyekeze yayo uhlelo olusemthethweni lokugonywa kwengane nentsha ukufaka imigomo ye-COVID-19.
CHOFOZA LAPHA UKUZE UTHOLA UHLELO LOKUSEBENZA IZINDABA ZEZIMpungushe
Uhlelo, olufakwe kusizindalwazi se-CDC, luncoma ukuthi izingane eziphakathi kwezinyanga eziyisithupha neneminyaka engu-18 ubudala kufanele zithole imithamo emibili yochungechunge oluyisisekelo phakathi kwamasonto amane kuya kwayisishiyagalombili ngokuhlukana – kulandelwa umthamo we-booster okungenani emasontweni ayisishiyagalombili kamuva.
